Results 71 to 80 of about 1,017 (103)

Tracking of Infectious Diseases in Shahr-i Sokhta (Burnt City) during the Bronze Age (ca. 3200-2200 BCE) through Anemic Signs Observed in Excavated Human Skeletons.

open access: yesIran J Public Health
Bizhani N   +9 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Sporadic Congenital Infantile Cortical Hyperostosis (Caffey's Disease)

American Journal of Perinatology, 1998
Prognosis of congenital infantile cortical hyperostosis (Caffey's disease) is poor particularly in premature babies. Two cases are presented of congenital Caffey's disease in premature babies. The first baby was hydropic at birth and had cortical hyperostosis involving the mandible and long bones of right upper limb and both lower limbs.
K I, Al-Tawil   +3 more
openaire   +2 more sources

Cortical hyperostosis following long-term administration of prostaglandin E1 in infants with cyanotic congenital heart disease

The Journal of Pediatrics, 1980
PROSTAGLANDIN Et or E~ has been widely used in infants with ductus dependen t cyanotic congeni ta l hear t diseaseY ~ Recent reports have shown encouraging results with long-term low-dose adminis t ra t ion in selected patients, and there have been no significant side effects?
K, Ueda   +6 more
openaire   +2 more sources

Reversibility of cortical hyperostosis following long-term prostaglandin E1 therapy in infants with ductus-dependent congenital heart disease

Pediatric Radiology, 1988
Two neonates with complex cyanotic congenital heart disease, receiving long-term prostaglandin E1 infusion, for 59 and 78 days respectively, demonstrated significant radiographic changes of symmetric cortical hyperostosis of the long bones. Bone biopsies from one of the patients elucidated the histological changes and serial X-rays revealed regression ...
A, Høst, S, Halken, P E, Andersen
openaire   +2 more sources

Cortical hyperostosis: a complication of prostaglandin E1 treatment in congenital heart disease.

Journal belge de radiologie, 1990
Prostaglandin E1 (PGE1) is an essential drug for infants with ductal-dependent congenital heart disease. Cortical hyperostosis of the long bones is one of the complications during and after PGE1 therapy and should be considered in the differential diagnosis of periostitis in the infant.
M H, Smet   +4 more
openaire   +1 more source

Home - About - Disclaimer - Privacy